Insomnia Therapeutics Market Growth, Overview, Key Manufacturers, Scope, Analysis And Forecasts To 2025
“The Global Insomnia Therapeutics Market is expected to reach USD 3.45billion by 2025, according to a new report. The market is primarily driven by thepresence of patented molecules, potential clinical pipeline candidates, rising stress level,and increase in geriatric population who find it difficult to fall asleep.”
“The Global Insomnia Therapeutics Market is expected to reach USD 3.45billion by 2025, according to a new report. The market is primarily driven by thepresence of patented molecules, potential clinical pipeline candidates, rising stress level,and increase in geriatric population who find it difficult to fall asleep.”
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Insomnia</strong> <strong>Therapeutics</strong> <strong>Market</strong> <strong>Growth</strong>, <strong>Overview</strong>, <strong>Key</strong><br />
<strong>Manufacturers</strong>, <strong>Scope</strong>, <strong>Analysis</strong> <strong>And</strong> <strong>Forecasts</strong> <strong>To</strong> <strong>2025</strong><br />
“The Global <strong>Insomnia</strong> <strong>Therapeutics</strong> <strong>Market</strong> is expected to reach USD<br />
3.45billion by <strong>2025</strong>, according to a new report. The market is primarily<br />
driven by thepresence of patented molecules, potential clinical pipeline<br />
candidates, rising stress level,and increase in geriatric population who find<br />
it difficult to fall asleep.”<br />
The Global <strong>Insomnia</strong> <strong>Therapeutics</strong> <strong>Market</strong> is expected to reach USD 3.45billion by <strong>2025</strong>, according to a new<br />
report. The market is primarily driven by thepresence of patented molecules, potential clinical pipeline<br />
candidates, rising stress level,and increase in geriatric population who find it difficult to fall asleep. Increase in<br />
prevalence of insomnia &awareness about this conditionand availability of safer drugs are anticipated to fuel<br />
revenue growth.<br />
<strong>Insomnia</strong> is estimated to affect approximately 35% of the global population. Differentpatternsof the condition<br />
include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent<br />
awakenings&awakening too early with trouble sleepingagain. Long-terminsomnia can hamper everyday life,<br />
which may result in nonproductive work hours. If left untreated, this conditionmay lead to severe depression<br />
and nervous breakdown of the patient.<br />
Request A Sample copy of This Report @<br />
http://www.hexareports.com/report/insomnia-therapeutics-market/request-sample<br />
Follow Us:
Factors influencing insomnia therapeutics market growth includerising stress level, presence of patented<br />
molecules in the market, potentialdrugs in clinical pipeline, introduction of technologically advanced medical<br />
devices, and growinggeriatric population.Growing awareness about the impact of sleep deprivation on<br />
everyday lifeis anticipated to increaseadoption rate of various treatments for insomnia, which is expected to<br />
lead to revenue growth of the insomnia therapeutics market.<br />
Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and<br />
antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are<br />
available in the market.Launch of Eisai's Lemborexant is expected to cater to unmet medical needs in this<br />
segment and fuel growth of this market over the forecast period. According toUnited Nations (UN) report in<br />
2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach<br />
around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population<br />
base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.<br />
Browse Detail Report With TOC @<br />
http://www.hexareports.com/report/insomnia-therapeutics-market<br />
Further <strong>Key</strong> Findings From the Report Suggest:<br />
• North America held majority of the share in 2016 due to increase inawareness about diseases, growing<br />
geriatricpopulation, and high adoption of therapeutics for treatment.<br />
• The U.S. dominated North America owing to the presence of largest sleep-deprived population and use<br />
of patented drugs for treatment.<br />
• Japan is the second largest market after the U.S. Asia Pacific is expected to be the fastest<br />
growingmarket due to the presence ofemerging economies like China & India and launch of new drugs.<br />
• Some of the key players are Takeda Pharmaceutical Co. Ltd.; Vanda Pharmaceuticals; Merck & Co,<br />
Inc.;Pfizer Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N. V.; Sumitomo Dainippon Pharma Co.,<br />
Ltd.; Sanofi; Paratek Pharmaceuticals;and Ebb <strong>Therapeutics</strong>.<br />
Browse More Healthcare Related <strong>Market</strong> Research Reports:<br />
• Stethoscope <strong>Market</strong> <strong>Analysis</strong> By Type (Manual Stethoscopes, Electronic Stethoscopes), By Region (North<br />
America, Europe, Asia Pacific, Latin America, MEA), <strong>And</strong> Segment <strong>Forecasts</strong>, 2014 - <strong>2025</strong>-<br />
http://www.hexareports.com/report/stethoscopes-market<br />
• Healthcare Staffing <strong>Market</strong> <strong>Analysis</strong> By Service (Travel Nurse, Per Diem Nurse, Locum Tenens, Allied<br />
Healthcare), By Region (North America, Europe, Asia Pacific, Latin America, MEA), <strong>And</strong> Segment <strong>Forecasts</strong>,<br />
2014 - <strong>2025</strong>-<br />
http://www.hexareports.com/report/healthcare-staffing-market<br />
Follow Us:
About Us:<br />
Hexa Reports is a market research and consulting organization, offering industry reports,<br />
custom research and consulting services to a host of key industries across the globe. We offer<br />
comprehensive business intelligence in the form of industry reports which help our clients<br />
obtain clarity about their business environment and enable them to undertake strategic growth<br />
initiatives.<br />
Contact Information:<br />
Ryan Shaw<br />
Felton Office Plaza,<br />
6265 Highway 9,<br />
Felton, California, 95018,<br />
United States<br />
Phone Number<br />
1-800-489-3075<br />
Email Us: sales@hexareports.com<br />
Our Website: http://www.hexareports.com/<br />
Follow Us:
Change language